Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Medvest Capital is a venture capital firm founded in 2013 and headquartered in Palm Beach Gardens, Florida. The firm focuses on early-stage investments in medical device companies, aiming to improve patient outcomes, decrease delivery costs, and minimize provider risk. Since its inception, Medvest has established itself as a key player in the healthcare investment space, particularly in the medical device sector.
As of now, Medvest Capital manages approximately $6 million in revenue derived from management fees and carry. The firm operates with a small team of around three employees, allowing for a focused and hands-on approach to its investments. Medvest Capital has built a portfolio of six companies, demonstrating its commitment to supporting innovative solutions in healthcare. The firm is strategically located in Florida, a growing hub for medical technology and innovation.
Medvest Capital invests primarily in early-stage medical device companies, with a specific focus on the healthcare, biotech, and medical device sectors. The firm targets investment amounts ranging from $1 million to $3 million, allowing for significant support during critical early development stages. Medvest collaborates closely with management teams to validate market feasibility and expedite product development, ensuring that portfolio companies are well-positioned for success.
The firm’s investment strategy emphasizes improving patient outcomes while reducing costs and provider risk. Medvest Capital is particularly interested in companies that demonstrate innovative approaches to medical technology and life science tools. This focus allows the firm to maintain a flexible investment thesis, accommodating a range of opportunities within the healthcare vertical.
Medvest Capital's portfolio includes six notable companies, each contributing to advancements in healthcare technology:
These companies reflect Medvest's commitment to investing in technologies that improve patient care and operational efficiency within the healthcare sector.
David Cash - Managing Partner: David has extensive experience in venture capital and healthcare investments, having led multiple successful funding rounds in the medical device sector.
Todd Saunders - Partner: Todd specializes in early-stage investments and has a strong background in operational management within healthcare companies.
David Menkhaus - Partner: David brings expertise in market analysis and product development, having worked with various startups in the medical technology field.
To pitch Medvest Capital, founders should send an email to info@medvestcap.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market analysis, and financial projections. The firm appreciates clarity and detail in the initial communication.
Response times may vary, but founders can generally expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory.
In March 2022, Medvest Capital participated in a $30 million oversubscribed Series B round for Osteal Therapeutics, a clinical-stage biopharmaceutical company focused on musculoskeletal infections. The firm returned as an investor in the subsequent Series C round in September 2023, which raised $23 million.
Additionally, Medvest Capital led a $2.3 million Series B investment in BrightSpec, a life science tools company, and participated in its Series C round in December 2022, which raised $18.4 million.
What are Medvest Capital's investment criteria?
Medvest Capital focuses on early-stage medical device companies, particularly those that can demonstrate innovative solutions in healthcare. The firm typically invests between $1 million and $3 million.
How can I apply or pitch to Medvest Capital?
Founders can reach out to Medvest Capital via email at info@medvestcap.com to initiate a pitch. It is advisable to include a detailed business plan and financial projections in the initial communication.
What makes Medvest Capital different from other venture capital firms?
Medvest Capital distinguishes itself through its specialized focus on medical devices and its collaborative approach with portfolio companies. The firm actively engages with management teams to validate market feasibility and expedite product development.
What is the geographic scope of Medvest Capital's investments?
Medvest Capital primarily invests in companies located in the United States, focusing on the North American healthcare market.
What is Medvest Capital's post-investment involvement like?
Medvest Capital provides ongoing support to its portfolio companies, assisting with market validation, product development, and implementing sustainable business practices to ensure long-term success.
What is the typical check size for investments?
Medvest Capital typically invests between $1 million and $3 million in each portfolio company, allowing for substantial support during critical early stages of development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.